{"id":654,"date":"2024-03-08T15:40:47","date_gmt":"2024-03-08T14:40:47","guid":{"rendered":"https:\/\/www.novacos-law.com\/en\/?p=654"},"modified":"2024-03-08T15:46:04","modified_gmt":"2024-03-08T14:46:04","slug":"27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/","title":{"rendered":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs"},"content":{"rendered":"<p>Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of &#8220;Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs&#8221; at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in the future as part of the EU&#8217;s Green Deal. The legal requirements for this are currently being created or tightened by the European legislator. The presentation will provide an overview of the (new) requirements.<\/p>\n<p>Further information can be found <a href=\"https:\/\/www.uni-marburg.de\/de\/fb01\/forschung\/forschungszentrum-und-projekte\/forschungsstellen\/pharmarecht\/veranstaltungen-weiterbildungen\/marburger-gespraeche-zum-pharmarecht\/die-27-marburger-gespraeche-zum-pharmarecht\">here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of &#8220;Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs&#8221; at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-654","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of &quot;Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs&quot; at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Irene Weigel\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#article\",\"name\":\"27. Marburger Gespr\\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \\u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs | NOVACOS\",\"headline\":\"27. Marburger Gespr\\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\",\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"},\"datePublished\":\"2024-03-08T15:40:47+01:00\",\"dateModified\":\"2024-03-08T15:46:04+01:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#webpage\"},\"articleSection\":\"Events\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#listItem\",\"name\":\"27. Marburger Gespr\\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#listItem\",\"position\":3,\"name\":\"27. Marburger Gespr\\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/\",\"name\":\"Irene Weigel\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Irene Weigel\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#webpage\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/\",\"name\":\"27. Marburger Gespr\\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \\u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs | NOVACOS\",\"description\":\"Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of \\\"Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\\\" at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2024\\\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/irene\\\/#author\"},\"datePublished\":\"2024-03-08T15:40:47+01:00\",\"dateModified\":\"2024-03-08T15:46:04+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs | NOVACOS","description":"Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of \"Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\" at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in","canonical_url":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#article","name":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs | NOVACOS","headline":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs","author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"},"datePublished":"2024-03-08T15:40:47+01:00","dateModified":"2024-03-08T15:46:04+01:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#webpage"},"isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#webpage"},"articleSection":"Events"},{"@type":"BreadcrumbList","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","position":1,"name":"Home","item":"https:\/\/www.novacos-law.com\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","name":"Events"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","position":2,"name":"Events","item":"https:\/\/www.novacos-law.com\/en\/category\/events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#listItem","name":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#listItem","position":3,"name":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs","previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/events\/#listItem","name":"Events"}}]},{"@type":"Organization","@id":"https:\/\/www.novacos-law.com\/en\/#organization","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","url":"https:\/\/www.novacos-law.com\/en\/"},{"@type":"Person","@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author","url":"https:\/\/www.novacos-law.com\/en\/author\/irene\/","name":"Irene Weigel","image":{"@type":"ImageObject","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g","width":96,"height":96,"caption":"Irene Weigel"}},{"@type":"WebPage","@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#webpage","url":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/","name":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs | NOVACOS","description":"Our partner Maria Heil and senior associate Dr. Julia Eickbusch will speak on the topic of \"Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\" at the 27th Marburg Talks on Pharmaceutical Law on March 15, 2024. ESG issues will play a major role for the healthcare industry in","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/#breadcrumblist"},"author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"creator":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/irene\/#author"},"datePublished":"2024-03-08T15:40:47+01:00","dateModified":"2024-03-08T15:46:04+01:00"},{"@type":"WebSite","@id":"https:\/\/www.novacos-law.com\/en\/#website","url":"https:\/\/www.novacos-law.com\/en\/","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","inLanguage":"en-GB","publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"}}]}},"aioseo_meta_data":{"post_id":"654","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2024-03-08 13:11:04","updated":"2025-07-25 09:26:13","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\/category\/events\/\" title=\"Events\">Events<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) \u2013 Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.novacos-law.com\/en"},{"label":"Events","link":"https:\/\/www.novacos-law.com\/en\/category\/events\/"},{"label":"27. Marburger Gespr\u00e4che zum Pharmarecht (March 14 and 15, 2024, Marburg) &#8211; Sustainability in the pharmaceutical industry: design and product requirements using the example of take-back programs","link":"https:\/\/www.novacos-law.com\/en\/2024\/27-marburger-gesprache-zum-pharmarecht-14-and-15-march-2024-marburg-sustainability-in-the-pharmaceutical-industry-design-and-product-requirements-using-the-example-of-take-back-programs\/"}],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=654"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}